Background: labour is a stressful event for the fetus but is well tolerated by most fetuses.
However, in some infants stress of labour in terms of metabolic acidosis can lead to Hypoxic …

Aims: We aimed to demonstrate the effect of magnesium sulfate for fetal neuroprotection on
maternal and neonatal outcomes of pregnants delivered before 32 weeks.

THE EFFICACY AND SAFETY OF MAGNESIUM SULPHATE FOR NEONATAL
NEUROPROTECTION IN PATIENTS WITH IMMINENT PRETERM DELIVERIES: EXPERIENCE …

Magnesium sulfate in some dosage given before very preterm pregnancy delivery is
beneficial for fetal neuroprotection. The exact dose, duration, and timing of administration to …

Background It is important to establish whether research recommendations regarding
magnesium sulphate for neuroprotection can be readily translated into clinical practice and …

Abstract Background and Aim: In recent times, survival of preterm infants has improved
drastically. In addition to significant contribution to neonatal mortality, impact of prematurity …

Objective: to review the literature available on the use of magnesium sulfate for fetal
neuroprotection. Recent findings: Nowadays, randomized controlled trials and metanalyses …

Purpose To review the effect of intravenous magnesium in obstetrics on fetal/neonatal
neuroprotection. Methods A systematic review of published studies. Results Five …

The administration of magnesium sulphate to mothers at risk for preterm birth for fetal
neuroprotection has demonstrated to reduce the risk of cerebral palsy and gross motor …

ABSTRACT Background: Magnesium sulfate (MgSO4) can be used for the primary
prevention of cerebral palsy in preterm infants less than 37 weeks of gestational age. Aim …